Volume 63, 2022-6-1, Pages i-186

Articles in this issue:

1. Editorial Board

2. Central nervous system disease in phase III studies for advanced HER2 positive breast cancer: A review

3. Effects of physical exercise on cognitive function of breast cancer survivors receiving chemotherapy: A systematic review of randomized controlled trials

4. The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases

5. “The emerging role of capivasertib in breast cancer”

6. A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

7. Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis

8. Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial

9. Clinical characteristics and survival outcome of patients with estrogen receptor low positive breast cancer

10. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy

11. Exploring breast surgeons’ reasons for women not undergoing immediate breast reconstruction

12. Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group

13. Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort

14. Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction

15. Experiences of health professionals treating women diagnosed with cancer during pregnancy and proposals for service improvement

16. Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort

17. Geriatric assessment tool application in treatment recommendations for older women with breast cancer

18. New Zealand experience with implementation of the ESO-ESMO consensus guidelines for advanced breast cancer-report of achievements and lessons learned

19. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

20. The continuing conundrum in oligometastatic breast carcinoma: A real-world data

21. “Alas … my sickness becomes my family's burden”: A nested qualitative study on the experience of advanced breast cancer patients across the disease trajectory in Indonesia

22. Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC